ScholarIQanswers from OpenAlex & ORCID
Elizabeth J. Perlman
ResearcherPublications, citations & collaboration network
Elizabeth J. Perlman is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Elizabeth J. Perlman have?
ScholarIQindexed works
Elizabeth J. Perlman has 447 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Elizabeth J. Perlman have?
ScholarIQcitation count
Elizabeth J. Perlman has 24,303 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Elizabeth J. Perlman?
ScholarIQh-index
Elizabeth J. Perlman has an h-index of 88 in OpenAlex.
What is the i10-index of Elizabeth J. Perlman?
ScholarIQi10-index
Elizabeth J. Perlman has an i10-index of 233 in OpenAlex.
What is the ORCID of Elizabeth J. Perlman?
ScholarIQorcid
The ORCID for Elizabeth J. Perlman is on the source record.
What is the OpenAlex record for Elizabeth J. Perlman?
ScholarIQopenalex
The OpenAlex for Elizabeth J. Perlman is on the source record.
What are the most-cited papers on Elizabeth J. Perlman?
ScholarIQmost cited works
Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report From the National Wilms Tumor Study Group
Paul E. Grundy, Norman E. Breslow, Sierra Li, Elizabeth J. Perlman, J. Bruce Beckwith, Michael L. Ritchey, Robert C. Shamberger, Gerald M. Haase, Giulio J. D’Angio, Milton H. Donaldson, Max J. Coppes, Marcio H. Malogolowkin, Patricia Shearer, Patrick R. Thomas, Roger M. Macklis, Gail E. Tomlinson, Vicki Huff, Daniel M. Green
Treatment of Anaplastic Histology Wilms' Tumor: Results From the Fifth National Wilms' Tumor Study
Jeffrey S. Dome, Cecilia A. Cotton, Elizabeth J. Perlman, Norman E. Breslow, John A. Kalapurakal, Michael L. Ritchey, Paul E. Grundy, Marcio H. Malogolowkin, J. Bruce Beckwith, Robert C. Shamberger, Gerald M. Haase, Max J. Coppes, Peter F. Coccia, Morris Kletzel, Robert M. Weetman, Milton H. Donaldson, Roger M. Macklis, Daniel M. Green
Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study
Linda Granowetter, Richard B. Womer, Meenakshi Devidas, Mark Krailo, Chenguang Wang, Mark L. Bernstein, Neyssa Marina, Patrick J. Leavey, Mark C. Gebhardt, John H. Healey, Robert C. Shamberger, Allen M. Goorin, James S Miser, James S. Meyer, Carola A.S. Arndt, Scott L. Sailer, Karen J. Marcus, Elizabeth J. Perlman, Paul S. Dickman, Holcombe E. Grier
Management of Wilms' tumour: current practice and future goals
John A. Kalapurakal, Jeffrey S. Dome, Elizabeth J. Perlman, Marcio H. Malogolowkin, Gerald M. Haase, Paul E. Grundy, Max J. Coppes
Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group
Marcio H. Malogolowkin, Cecilia A. Cotton, Daniel M. Green, Norman E. Breslow, Elizabeth J. Perlman, James S Miser, Michael L. Ritchey, Patrick R. Thomas, Paul E. Grundy, Giulio J. D’Angio, J. Bruce Beckwith, Robert C. Shamberger, Gerald M. Haase, Milton H. Donaldson, Robert M. Weetman, Max J. Coppes, Patricia Shearer, Peter F. Coccia, Morris Kletzel, Roger M. Macklis, Gail E. Tomlinson, Vicki Huff, Robert Newbury, Douglas A. Weeks